Project Grant R01DK139321

Award Date 12/19/24
Completion Date 11/30/29
Dollars Obligated $1.7M
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60612, USA
Similar Awards
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), is focused on investigating the mechanisms of renal lipotoxicity and its contribution to chronic kidney disease (CKD). The total funding amount is $128,286.00, with an award date of December 16, 2024 and an ultimate completion date of June 30, 2027. The primary goals of the research are to...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $725,420 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to develop an optimized allysine-targeted positron emission tomography (PET) probe and validate it in animal models and human renal biopsy samples. The goal is to establish a non-invasive...
This $152,453 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support the development and validation of a deep learning approach to automatically assess kidney vascular pathology and predict cardiovascular risk from digitized kidney biopsy images. The award will be used by the Boston Medical Center Corporation to: 1) develop and validate an...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will fund research to develop an AI-assisted system for interpreting kidney biopsy images to reduce inappropriate organ discards. The $1,470,094 award to New York University School of Medicine aims to: (1) construct a comprehensive atlas of kidney biopsy histopathology using...
This federal Project Grant award for $892,433.00, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research aimed at understanding the role of eicosanoids (bioactive lipid molecules) in the development of chronic kidney disease (CKD) and associated cardiovascular risk. The research project, led by the principal investigator at Cedars-Sinai Medical Center,...
This $728,513 federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) aims to develop and validate renal quantitative susceptibility mapping (QSM) as a novel biomarker for detecting and quantifying hemorrhagic cysts in patients with autosomal dominant polycystic kidney disease (ADPKD). The key objectives are to: 1) develop robust and accurate renal...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to use a systems biology approach to identify gene regulatory networks related to hypoxia inducible factor-1a (HIF1a) in the kidney cortex and medulla. The $117,000 award, which runs from January 1, 2025 to December 31, 2026, will focus on validating predicted transcription factor...
This federal Project Grant award, funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to define the role of iron homeostasis in the responses of proximal tubular epithelial cells to kidney fibrosis, which is a key driver of chronic kidney disease (CKD) progression. The $199,922 award to Weill Medical College of Cornell University will support experiments to...
This $209,832 Project Grant award was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant will fund a 5-year research project led by Dr. Qandeel Soomro at the NYU Grossman School of Medicine to investigate the role of the autonomic nervous system in the cardiovascular complications of chronic kidney disease (CKD). The project aims to deeply phenotype...
This $820,119 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) supports research focused on elucidating the mechanobiological functions of novel cytoskeletal structures in podocytes to reveal new therapeutic opportunities for kidney glomerular diseases. The primary research aims to better understand the mechanisms underlying podocyte homeostasis,...

This federal Project Grant award of $1,695,959.00 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The primary goal of the project is to evaluate the use of gadolinium-free kidney functional magnetic resonance imaging (fMRI) to identify high-risk phenotypes of chronic kidney disease (CKD). The project will analyze fMRI data from 420 participants with CKD recruited across 7 sites, and conduct 2-year follow-up fMRI scans on a subset of 210 participants. The researchers will test the associations between fMRI biomarkers and chronic histopathologic lesions, as well as changes in kidney function over time. The project will also extract fMRI radiomic features to identify potential imaging sub-phenotypes of CKD. Relevant sub-awards will support the coordination of fMRI scans, data analyses, and interpretation of results across the participating research sites, which include institutions such as the Icahn School of Medicine at Mount Sinai, University of Texas Southwestern Medical Center, and University of North Carolina at Chapel Hill.

Generated 7/1/25, 4:01 AM